Document is current
Any future updates will be listed below
-
Authors
Seo, Jaein https://orcid.org/0000-0003-1486-5876
Heidenreich, Sebastian https://orcid.org/0000-0002-1909-5770
Aldalooj, Esraa https://orcid.org/0000-0002-2786-1041
Poon, Jiat Ling https://orcid.org/0000-0001-7038-2102
Spaepen, Erik https://orcid.org/0000-0001-7590-7844
Eby, Elizabeth L. https://orcid.org/0000-0003-3896-6583
Newson, Rachel S. https://orcid.org/0000-0002-2653-5797
-
Funding
Funding for this research was provided by:
Eli Lilly and Company (Eli lilly funded Evidera to perform the study)
- License Information
-
More Information
Article History
Accepted: 3 November 2022
First Online: 28 November 2022
Declarations
:
: SH, JS, EA are employees of Evidera by PPD, which was paid by Eli Lilly & Co. for work related to this study. ES is a contractor funded by Eli Lilly & Co. J-L P, EE, RN are employees and shareholders in Eli Lilly & Co.
: This study and medical writing were funded by Eli Lilly & Co.
: SH: conceptualization, methodology, writing, supervision; JS: conceptualization, methodology, writing, project administration; EA: formal analysis, writing—review and editing; JLP: conceptualization, methodology, writing—review and editing; ES: conceptualization, methodology, writing—review and editing; EE: conceptualization, methodology, writing—review and editing; RSN: conceptualization, methodology, supervision, project administration, writing—review and editing.
: The study was approved by Ethical and Independent Review Services (nos. 20182-01 and 20182-01A). Upon completion of the study, each participant was remunerated for their time with a cash equivalent in panel currency/voucher.
: The datasets generated during and/or analyzed during the current study are not publicly available as no consent was sought from participants to allow sharing of data with third parties.
